According to the AI express, Mingde Bio (SZ 002932, closing price: 97 yuan) issued an announcement on the evening of July 22 that Chen Lili, the company's controlling shareholder and actual controller, released about 4.84 million shares of the company's shares originally pledged to Huatai Securities on July 21, 2020, accounting for 23.93% of the shares held by it. As of the date of this announcement, chen Lili, the controlling shareholder and actual controller of the company, has accumulated 5,900,000 shares pledged, accounting for 29.15% of the shares held by him.
According to the 2019 annual report, the main business of Mingde Bio is pharmaceutical manufacturing, accounting for 100.0% of revenue.
The chairman and general manager of Mingde Bio are Chen Lili, female, 46 years old, Chinese nationality, no right of permanent residence abroad, doctoral degree.
According to the "Brand Value List of Listed Companies in China", the brand value of Mingde Bio is 129 million yuan, ranking 325th in the pharmaceutical industry.
Per AI review: 1. The pledge rate of major shareholders is 51.30%, and no regulatory letter has been received in the past six months.
Every headline (nbdtoutiao) - interview with Lan Weiguang, chairman of Sanda Film: Isn't the science and technology innovation board "tailor-made for us science and technology innovators"?
(Reporter Bi Luming)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice, and are verified before use. Do so at your own risk.
![Fujian opera Wudan Chen Lili appeared on CCTV on the evening of the 8th[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)